T-Jaki 5 mg Tablet

Get a Price/Quote

MOQ : 10 Boxes

T-Jaki 5 mg Tablet Specification

Packaging Type
Strip

Dosage Form
Oral solid dosage

Pacakaging (Quantity Per Box)
Typically 10 strips per box (100 tablets)

Life Span
24 months from manufacturing date

Salt Composition
Tofacitinib

Origin of Medicine
India

Indication
Moderate to severe rheumatoid arthritis, psoriatic arthritis, ulcerative colitis

Brand Name
T-Jaki

Drug Type
Allopathic

Ingredients
Tofacitinib 5 mg

Physical Form
Tablet

Function
Immunomodulatory; Janus kinase (JAK) inhibitor

Recommended For
Rheumatoid arthritis, Psoriatic arthritis, Ulcerative colitis (as prescribed by physician)

Dosage
As directed by physician

Dosage Guidelines
Take orally, do not crush or chew, follow prescribed schedule strictly

Suitable For
Adults

Quantity
1 strip (usually 10 tablets per strip)

Storage Instructions
Store in a cool, dry place below 30C. Protect from light and moisture.

Therapeutic Class
Disease Modifying Anti-Rheumatic Drug (DMARD)

Prescription Required
Yes

Route of Administration
Oral

Color
White or off-white

Shape
Film-coated, oval-shaped

Marketed By
Zydus Healthcare Limited

Caution
Use with caution in hepatic or renal impairment

Side Effects
Infections, headache, high blood pressure, liver enzyme elevations

Warning
Not to be used during pregnancy or lactation unless prescribed

Patient Advice
Regular monitoring of blood counts and liver function recommended during therapy

Approval
Approved by DCGI (Drug Controller General of India)

T-Jaki 5 mg Tablet Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Boxes Per Month

Delivery Time
7 Days

Main Domestic Market
All India

T-Jaki 5 mg Tablet About

Capitalise on the formidable efficacy of T-Jaki 5 mg Tablet, formulated with superior quality Tofacitinib for the management of moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. This excellent film-coated, oval-shaped tablet offers immunomodulatory benefits through Janus kinase (JAK) inhibition. Approved by DCGI and marketed by Zydus Healthcare Limited, T-Jaki requires a prescription and strict adherence to recommended dosage. Explore its advanced DMARD capabilities-regular monitoring is essential. Offer your patients a solution suitable for adults, with a shelf life of 24 months. Not for use in pregnancy or lactation without medical advice.

Targeted Application and Multifold Advantages

T-Jaki 5 mg Tablet is specifically designed for use in adult patients needing disease modulation for rheumatoid arthritis, psoriatic arthritis, or ulcerative colitis. The plant application of this medicine ensures excellent quality and consistent results. Its general use extends to multiple autoimmune disorders under physician supervision. The advantage lies in its targeted immunomodulatory action, supporting improved symptoms and better life quality while minimizing disease progression.

Sample Policy, Delivery, and Transport Process

T-Jaki 5 mg Tablet sample requests are processed with care; goods transport is ensured through regulated channels to both domestic markets and international clients. Delivery time is subject to standard practices and order size, typically completed within a reliable timeframe. Products are handed over via designated FOB ports, adhering to best practices for storage and safety. Clients can expect professional handling throughout the shipping journey, with prompt notification upon dispatch.

FAQ's of T-Jaki 5 mg Tablet:

Q: How should T-Jaki 5 mg Tablet be taken for optimal results?

A: T-Jaki 5 mg Tablet should be taken orally, as prescribed by your physician. Do not crush or chew the tablet, and follow the dosing schedule diligently for best results.

Q: What are the main uses of T-Jaki 5 mg Tablet?

A: The tablet is primarily used to manage moderate to severe cases of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis as directed by a healthcare professional.

Q: When is T-Jaki 5 mg Tablet contraindicated?

A: T-Jaki should not be used during pregnancy or lactation unless clearly prescribed. It is also to be used with caution in patients with hepatic or renal impairment.

Q: What side effects may be associated with T-Jaki 5 mg Tablet?

A: Possible side effects include infections, headache, increased blood pressure, and elevated liver enzymes. Regular monitoring of blood counts and liver function is recommended.